BackX4 Pharmaceuticals Overview
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Target Price

Explore X4 Pharmaceuticals's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.12

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-10Wells Fargo$11252.6% upsideOpen
2026-06-02Leerink PartnersThomas Smith$12284.6% upsideOpen
2026-03-09Guggenheim$12284.6% upsideOpen
2025-12-05Stifel NicolausJames Condulis$10220.5% upsideOpen
2025-11-05Stifel NicolausStephen Willey$7.5140.4% upsideOpen
2025-08-29Stifel NicolausStephen Willey$9188.5% upsideOpen
2025-08-13H.C. WainwrightSwayampakula Ramakanth$3.512.2% upsideOpen
2022-12-22Cantor Fitzgerald$33.8% downsideOpen
2022-12-11Piper SandlerEdward Tenthoff$33.8% downsideOpen
2022-11-30H.C. Wainwright$560.3% upsideOpen

X4 Pharmaceuticals (XFOR) FAQ

Stockcircle tracks target price for X4 Pharmaceuticals (XFOR), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for X4 Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main XFOR overview so you can move from this figure to the surrounding analysis quickly.